Rosendale Introduces Drug Pricing Transparency, Accountability Act
U.S. Rep. Matt Rosendale, R-Mont., introduced the Drug Pricing Transparency and Accountability Act. This bill would hold hospitals accountable to their patients by encouraging financial transparency and tightening the current 340B drug pricing program.
Section 340B of the Public Health Service Act allows certain hospitals and health care providers to obtain substantially discounted drugs from







